Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study)
NCT02221830
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
66
Enrollment
OTHER
Sponsor class
Conditions
Preeclampsia
Interventions
DRUG:
Oxytocin
DRUG:
Placebo
Sponsor
University of Colorado, Denver